Main Session
Sep
29
EDU 32 - ASTRO/SNO Joint Session: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?
Radiation Therapy for Grade 2-3 IDH-mutant Gliomas: Evidence, Innovation, and Evolving Practices
Presenter(s)
Martin Tom, MD - The University of Texas MD Anderson Cancer Center, Houston, TX